This financing will fuel further international expansion, new product development and launches. It will continue to support GC Aesthetics’ vision to become the world’s leading independent medical aesthetics company.
GC Aesthetics is a global leader in the aesthetic and plastic surgery market with their flagship brands: UK-based Nagor and France-based Eurosilicone. GC Aesthetics has had manufacturing plants in Europe for over 30 years, and plans further expansion of its operations in Europe to meet the growing demand. The company, whose products sell in over 90 countries, has been growing their business worldwide with a new executive team at the helm since the beginning of 2013.
GC Aesthetics chairman and Montreux Equity Partners managing director Daniel K Turner III noted Ayse and the GC Aesthetics management team are transforming the aesthetics market with their focus on the health and wellness of women.
"Our continued financial commitment demonstrates our excitement for GC Aesthetics growth prospects as it becomes a global market leader in aesthetics," Turner added.